In this context, only mice engrafted with CD319 high-expressing MM cell lines experienced a significant prolonged survival in response to the BsAb (i.e., ~40 days compared to ~30 days in the control group) (19). This evidence concerns the gene SLAMF7 and Miyoshi myopathy.